Agnieszka Winkler Navidea Biopharmaceuticals, Inc. (NAVB) insider trading activity

Agnieszka Winkler is Director of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 33,600 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Nov 30, 2021, when has been sold 1,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.6K

0% 3M change

0% 12M change

Total Value Held $0

Agnieszka Winkler Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 30 2021	BUY Grant, award, or other acquisition	-	1,250 Added 3.59%	33,600 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	32,350 Added 50.0%	32,350 Common Stock

Also insider at

VIRC

VIRCO MFG CORPORATION Consumer Cyclical

Director